… Inhaled dual-pharmacology compounds, combining … or synergistic bronchodilation over
either inhaled antimuscarinic … in COPD patients with low risk for exacerbations, more symptoms, …

… The face mask seal can impact facial and eye deposition of … of inhaled bronchodilators. Their
cost is greater than that of jet … driven nebulization produced a significant decrease in the risk …

… Some data suggest that the combination of an LABA and an inhaled corticosteroid (ICS)
attenuates the risk of overall mortality in asthma, but this point has not been proven. Meta-…

… opinion of the investigator increase the risk of adverse effects with treatment. … nebulized
albuterol and 0.5 mg nebulized ipratropium given. After completion of this second bronchodilator …

… of increased risk of systemic or ocular adverse events with … In conclusion, the addition of
once-daily inhaled budesonide … pre- and post-bronchodilator values for forced expiratory volume …

… The Pharmacopoeia recommends that eye drops must contain an antimicrobial agent (… a
risk of potentially severe eye infection as well as the alteration of the formulation. Eye drops are …

… of increased risk of side effects on the one hand and loss of efficacy on the other Citation[9].
The anticholinergic (AC) agents in clinical use as inhaled bronchodilators are synthetic …

… trials on the risk of mortality associated with inhaled tiotropium … the long term trials, using
Visual Rx version 2.0.The number … morbidity and the use of inhaled bronchodilators. Int J Chron …

… , which is similar to the 0.80 reduction in risk that we observed for inhaled corticosteroids
and the 0.78 reduction for the combination of inhaled corticosteroids and long-acting β-agonists …

… Combination long-acting inhaled bronchodilators are central to the management of patients
… ICS therapy in COPD patients is associated with increased risk of pneumonia.4, 5 Therefore, …